Clinical Research

The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder

Volume: 12 Number: 1 March 28, 2025
EN

The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder

Abstract

Aim: This study aimed to enhance conscious awareness of respiratory control in panic disorder patients to prevent panic attacks. Materials and Method: Thirty participants (aged 18–65) diagnosed with panic disorder were recruited from NP Istanbul Brain Hospital and NP Istanbul Medical Center. They were divided into two groups: one received only psychoeducation on breathing techniques, while the other received psychoeducation combined with visual biofeedback (Galvanic Skin Resistance, heart rate, respiratory depth, and skin temperature). Breathing training was conducted over four weeks, and outcomes were assessed using the Panic Agoraphobia Scale, State and Trait Anxiety Scale, and biofeedback metrics. Result: Both groups showed significant improvements in Panic Agoraphobia Scale scores and reductions in State and Trait Anxiety scores. The biofeedback group demonstrated more pronounced improvements in respiratory control, with significantly lower breathing rates in the final assessment. Conclusion: Respiratory biofeedback combined with psychoeducation effectively improves respiratory control and reduces anxiety symptoms in panic disorder patients.

Keywords

Supporting Institution

Yok

Ethical Statement

Non-Interventional Research Ethics Committee permission was received from Uskudar University with approval date 25.04.2019 and number 61351342-/2019-278.

Thanks

Teşekkürler

References

  1. 1. Kessler RC., Avenevoli, S., Costello, E.J. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the Na¬tional Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry, 2012;69(4):372–380. doi:10.1001/archgenpsychia¬try.2011.160
  2. 2. Bandelow MS, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Diaoluges Clin Neurosci, 2015;17(3):327-335. DOI: 10.31887/ DCNS.2015.17.3/bbandelow
  3. 3. Chisholm D, Sweeny K, Sheehan P. Scaling-up treatment of de¬pression and anxiety: a global return on investment analysis. Lancet Psychiatry, 2016;3(5):415–424. DOI:https://doi.org/10.1016/S2215- 0366(16)30024-4
  4. 4. Kroenke KS. Anxiety disorders in primary care: prevalence, im¬pairment, comorbidity, and detection. Annals of internal medicine, 2007;146(5), 317-325.
  5. 5. Carta MG, Moro MF, Aguglia E. The attributable burden of panic disor¬der in the impairment of quality of life in a national survey in Italy. Int J Soc Psychiatry, 2015;61:693–699. DOI: 10.1177/0020764015573848
  6. 6. Hayashi KM. Electroencephalogram abnormalities in panic disorder patients: a study of symptom characteristics and pathology. BioPsy¬choSocial medicine, 2010;4(1),9.
  7. 7. Kaiya H, Umekage T. Factors associated with the development of pan¬ic attack and panic disorder: Survey in Japanese population. Psychi¬atry Clin Neurosci, 2005;59:177-182. https://doi.org/10.1111/j.1440- 1819.2005.01354.x
  8. 8. Smoller JW, Gardner-Schuster E. The genetic basis of panic and pho¬bic anxiety disorders. Am J Med Genet Part C, 2010;148:118–126. https://doi.org/10.1002/ajmg.c.30174

Details

Primary Language

English

Subjects

Psychiatry

Journal Section

Clinical Research

Publication Date

March 28, 2025

Submission Date

August 13, 2024

Acceptance Date

January 17, 2025

Published in Issue

Year 2025 Volume: 12 Number: 1

APA
Burkovik, H. Y., Göçmen, B. S., & Metin, B. (2025). The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder. The Journal of Neurobehavioral Sciences, 12(1), 1-7. https://doi.org/10.32739/jnbs.12.1.1
AMA
1.Burkovik HY, Göçmen BS, Metin B. The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder. JNBS. 2025;12(1):1-7. doi:10.32739/jnbs.12.1.1
Chicago
Burkovik, Hatice Yıldız, Buse Sıdıka Göçmen, and Barış Metin. 2025. “The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder”. The Journal of Neurobehavioral Sciences 12 (1): 1-7. https://doi.org/10.32739/jnbs.12.1.1.
EndNote
Burkovik HY, Göçmen BS, Metin B (March 1, 2025) The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder. The Journal of Neurobehavioral Sciences 12 1 1–7.
IEEE
[1]H. Y. Burkovik, B. S. Göçmen, and B. Metin, “The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder”, JNBS, vol. 12, no. 1, pp. 1–7, Mar. 2025, doi: 10.32739/jnbs.12.1.1.
ISNAD
Burkovik, Hatice Yıldız - Göçmen, Buse Sıdıka - Metin, Barış. “The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder”. The Journal of Neurobehavioral Sciences 12/1 (March 1, 2025): 1-7. https://doi.org/10.32739/jnbs.12.1.1.
JAMA
1.Burkovik HY, Göçmen BS, Metin B. The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder. JNBS. 2025;12:1–7.
MLA
Burkovik, Hatice Yıldız, et al. “The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder”. The Journal of Neurobehavioral Sciences, vol. 12, no. 1, Mar. 2025, pp. 1-7, doi:10.32739/jnbs.12.1.1.
Vancouver
1.Hatice Yıldız Burkovik, Buse Sıdıka Göçmen, Barış Metin. The Impact of Respiratory Biofeedback Use on Symptom Severity in Panic Disorder. JNBS. 2025 Mar. 1;12(1):1-7. doi:10.32739/jnbs.12.1.1